November 18, 2026
Business

Corona Remedies IPO Day 1 LIVE: Issue booked 38% so far; GMP, subscription status, review, other details. Apply or not? – livemint.com(Soban News)

  1. Corona Remedies IPO Day 1 LIVE: Issue booked 38% so far; GMP, subscription status, review, other details. Apply or not?  livemint.com
  2. CORONA Remedies IPO: Should you apply?  Value Research
  3. Corona Remedies IPO Day 1: Issue subscribed 42% till now, GMP rises to ₹298 – should you subscribe?  livemint.com
  4. Corona Remedies IPO GMP: Initial public offering now open for subscription, check grey market premium  India TV News
  5. Pharma firm Corona Remedies mobilises ₹195 crore from anchor investors, days before initial share-sale opening for public subscription  MSN

​Corona Remedies IPO Day 1 LIVE: Issue booked 38% so far; GMP, subscription status, review, other details. Apply or not?  livemint.comCORONA Remedies IPO: Should you apply?  Value ResearchCorona Remedies IPO Day 1: Issue subscribed 42% till now, GMP rises to ₹298 – should you subscribe?  livemint.comCorona Remedies IPO GMP: Initial public offering now open for subscription, check grey market premium  India TV NewsPharma firm Corona Remedies mobilises ₹195 crore from anchor investors, days before initial share-sale opening for public subscription  MSN by Soban News (international And National News)

Related posts

India achieves significant milestone in its fight against TB; records 38% decline in TB mortality and 94% treatment success rate – News On AIR(Soban News)

News-Soban-Admin

‘Dhurandhar’ box office collection day 29 Vs ‘Tu Meri Main Tera Main Tera Tu Meri’ day 9 (LIVE): Ranveer – Times of India(Soban News)

News-Soban-Admin

Mint Explainer | Trai plans a cut in network spectrum charges—why it matters for telcos(Soban News)

News-Soban-Admin

Leave a Comment